Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Invacare Lifts Prices to Offset Rising Commodity, Freight Costs

By MedCity News - Updated Apr 6, 2017 at 10:08PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The price hikes didn't affect first-quarter results, but what about the rest of the year?

Home health products maker Invacare (NYSE: IVC) raised some prices earlier this year and may increase more to offset rising freight and commodity costs.

CEO Gerry Blouch said the rising costs didn't affect the company's first-quarter financial results much, but that could change during the rest of the year. Invacare reported adjusted first-quarter net earnings of $10.5 million, or 32 cents per share, a 37 percent increase compared to the like quarter last year.

The results beat the consensus Wall Street analysts' estimate of earnings of 25 cents per share.

"Commodity and freight costs continue to rise, but fortunately the company did not experience much pressure in the first quarter due to our supplier contracts," Blouch said during a conference call with analysts. "We'll begin to feel more of this pressure in the second quarter."

The company increased prices on some of its home health equipment in January, and its North America/Home Medical Equipment group recently announced price increases effective May 1. Its other business segments are reviewing whether freight and commodity-related price increases would be appropriate later in the year, Blouch said.

Blouch characterized the quarter as a "solid start" to the year. He pointed to a 6 percent rise in organic sales with increases in all business segments. Net sales in the quarter rose nearly 7 percent to $424 million. That figure also beat Wall Street's expectations of $406 million.

The sales boost was driven in part by oxygen concentrators, custom power and custom manual wheelchairs and beds, according to the company.

Invacare reconfirmed its earlier full-year guidance of adjusted earnings per share between $2.05 and $2.15.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invacare Corporation Stock Quote
Invacare Corporation
$2.41 (0.00%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.